Ulrike Bindl Email

Ulrike Bindl, based in Munich, BY, DE, is currently a Director Regulatory Affairs and Quality Germany at AstraZeneca Rare Disease Business Unit at Alexion Pharma Germany GmbH, bringing experience from previous roles at AstraZeneca Rare Disease Business Unit at Alexion Pharma Germany GmbH and Alexion Pharma Germany GmbH. Ulrike Bindl holds a 1992 - 1996 University of Regensburg. With a robust skill set that includes Management, Clinical Research, Good Clinical Practice Gcp, Clinical Trials, Pharmaceutical Industry and more, Ulrike Bindl contributes valuable insights to the industry. Ulrike Bindl has 3 emails on RocketReach.